James C. Gale, Director at INDEVUS PHARMACEUTICALS INC (IDEV), sold 92,475 shares at $7.30 ($675K) on 2007-06-15, disclosed to the SEC on 2007-06-18.
Open-market sale of $675k IDEV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.30 | 1,576 | $12K | 1.7% |
| 2 | $7.30 | 7,008 | $51K | 7.6% |
| 3 | $7.30 | 7,610 | $56K | 8.2% |
| 4 | $7.30 | 15,790 | $115K | 17.1% |
| 5 | $7.30 | 20,811 | $152K | 22.5% |
| 6 | $7.30 | 31,980 |
| $233K |
| 34.6% |
| 7 | $7.30 | 102 | $745 | 0.1% |
| 8 | $7.30 | 427 | $3K | 0.5% |
| 9 | $7.30 | 452 | $3K | 0.5% |
| 10 | $7.30 | 1,017 | $7K | 1.1% |
| 11 | $7.30 | 1,341 | $10K | 1.5% |
| 12 | $7.30 | 2,061 | $15K | 2.2% |
| 13 | $7.30 | 2,300 | $17K | 2.5% |
| Total | $7.30 avg | 92,475 | $675K | 100% |
| Filing → |
| TLGT | BUY | 2017-11-13 | $57K | — | Filing → |
| TLGT | BUY | 2016-03-14 | $74K | — | Filing → |
| IG | BUY | 2015-05-01 | $151K | — | Filing → |